A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 6, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
NSCLC
Interventions
DRUG

EIK1001

EIK1001 is a Toll like receptor 7/8 (TLR 7/8) agonist

DRUG

Pembrolizumab

PD-1 inhibitor

DRUG

Paclitaxel

Chemotherapy

DRUG

Pemetrexed

Chemotherapy

DRUG

Carboplatin

Chemotherapy

Trial Locations (39)

10016

RECRUITING

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

10022

RECRUITING

Weil Cornell Medical Center, New York

10461

RECRUITING

Albert Einstein College of Medicine, Jacobi Medical Center, The Bronx

10601

RECRUITING

Cancer and Blood Specialists of New York, White Plains Hospital, White Plains

11702

RECRUITING

New York Cancer and Blood Specialists, Babylon

20144

RECRUITING

Maryland Oncology, Columbia

21237

RECRUITING

Medstar Franklin Square Cancer Center at Loch Raven Campus, Baltimore

22031

RECRUITING

Virginia Cancer Specialists, Fairfax

22601

RECRUITING

Shenandoah Oncology, Winchester

24060

RECRUITING

Blue Ridge Cancer Care Oncology Associates SW VA, Blacksburg

28806

RECRUITING

Messino Cancer Centers, Asheville

30318

NOT_YET_RECRUITING

Atlanta Piedmont Hospital, Atlanta

32763

RECRUITING

Mid-Florida Hematology and Oncology Center, Orange

32806

RECRUITING

Orlando Health Cancer Institute, Orlando

33013

RECRUITING

Bioresearch Partner, Hialeah

33021

RECRUITING

Memorial Cancer Institute, Hollywood

33612

NOT_YET_RECRUITING

Moffitt Cancer Center, Tampa

36608

RECRUITING

Southern Cancer Care, Daphne

37909

RECRUITING

Tennessee Cancer Specialists, Knoxville

38120

RECRUITING

Baptist Cancer Center, Memphis

44718

RECRUITING

Gabrail Cancer Center, Canton

46202

RECRUITING

Indiana University Cancer Center, Indianapolis

60487

RECRUITING

Accelacare of Duly, Tinley Park

60714

RECRUITING

Illinois Cancer Specialists, Niles

66211

RECRUITING

Health Midwest Oncology Associates of Kansas, Overland Park

67214

RECRUITING

Cancer Center of Kansas, Wichita

76022

RECRUITING

Texas Oncology, Bedford, Bedford

76104

RECRUITING

The Center for Cancer and Blood Disorders, Fort Worth

78745

RECRUITING

Texas Oncology, Austin, Austin

80124

RECRUITING

Rocky Mountain Cancer, Lone Tree

85224

RECRUITING

Ironwood Cancer and Research Center, Chandler

90027

RECRUITING

California Research Institute, Los Angeles

90033

RECRUITING

University of Southern California, Norris Comprehensive Cancer Center, Los Angeles

92868

RECRUITING

Providence St Joseph Hospital, Center for Cancer Prevention and Treatment, Orange

93720

RECRUITING

California Cancer Care Associates for Research & Excellence, Fresno

95816

RECRUITING

Sutter Health Institute for Medical Research, Sacramento

96819

RECRUITING

Kaiser Permanente Hawaii, Honolulu

97401

RECRUITING

Willamette Valley, Eugene

07753

RECRUITING

Jersey Shore University Medical Center/Meridian Hematology & Oncology, Neptune City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Eikon Therapeutics

INDUSTRY